FindMyRecallSubscribe
Class II: temporary or reversible health riskCompleted

Viatris Cardura XL Recall

Cardura XL (doxazosin) extended release tablets 8mg, 30-count bottles, Rx Only Made in…

Viatris Inc · Canonsburg, PA

Risk level
Class II
Reported by FDA
Jul 24, 2024
Recall ID
D-0603-2024
Check your lot numberHow we source this data

Summary

Viatris recalled Cardura XL starting Apr 30, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0603-2024 on Jul 24, 2024. Reason: Failed Impurities/Degradation Specifications. Status: Completed.

Why it was recalled

Failed Impurities/Degradation Specifications

Product description

Cardura XL (doxazosin) extended release tablets 8mg, 30-count bottles, Rx Only Made in Singapore, Distributed by Roerig Division of Pfizer Inc, NY, NY 10017 NDC 0049-2080-10

Lot numbers, UPCs & expiration codes

Lot#: 8147041; Exp. June 2024 Lot#: 8163765; Exp. March 2025

Where it was sold

U.S. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0603-2024
Classification
Class II
Status
Completed
Recall initiated
Apr 30, 2024
FDA report date
Jul 24, 2024
Quantity
3,694 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Viatris Inc

Original FDA data

Every field from FDA enforcement report D-0603-2024, exactly as published.

Show all FDA fields
City
Canonsburg
State
PA
Status
Completed
Country
United States
Event ID
94519
Address
1000 Mylan Blvd
Code information
Lot#: 8147041; Exp. June 2024 Lot#: 8163765; Exp. March 2025
Postal code
15317-5853
Report date
Jul 24, 2024
Product type
Drugs
Recall number
D-0603-2024
Classification
Class II
Recalling firm
Viatris Inc
Product quantity
3,694 bottles
Reason for recall
Failed Impurities/Degradation Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Cardura XL (doxazosin) extended release tablets 8mg, 30-count bottles, Rx Only Made in Singapore, Distributed by Roerig Division of Pfizer Inc, NY, NY 10017 NDC 0049-2080-10
Distribution pattern
U.S. Nationwide
Recall initiation date
Apr 30, 2024
Initial firm notification
Letter
Center classification date
Jul 16, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0603-2024, published Jul 24, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls